Val-met, also known as valproic acid or valproate, is a chemical compound primarily used as an anticonvulsant and mood-stabilizing drug. It is commonly prescribed for the treatment of epilepsy, bipolar disorder, and to prevent migraine headaches. The substance is characterized by its ability to increase the levels of gamma-aminobutyric acid (GABA) in the brain, which helps to stabilize neuronal activity and reduce seizure frequency. Val-met is typically administered in various forms, including tablets, capsules, and liquid formulations. Its pharmacokinetics involve rapid absorption and metabolism in the liver, with a half-life that can vary based on individual factors. Side effects may include gastrointestinal disturbances, weight gain, and potential liver toxicity, necessitating regular monitoring of liver function during treatment. Additionally, valproic acid is known to have teratogenic effects, making it crucial for women of childbearing age to discuss risks with their healthcare provider. Overall, val-met is a vital therapeutic agent in managing certain neurological and psychiatric conditions.

val-met

14486-09-0: H-Val-Met-OH, Valylmethionine

H-Val-Met-OH is a synthetic compound that was created to have a structure similar to the natural amino acid histidine. The synthesis of H-Val-Met-OH was achieved by reacting 2,5-diaminopentane with formaldehyde in the presence of cellulose acetate as a reaction medium. This process produced a white solid material that was then purified using chromatography. The purity and yield were confirmed by high performance liquid chromatography (HPLC) analysis and nuclear magnetic resonance (NMR). In vitro studies showed that H-Val-Met-OH promotes brain derived neurotrophic factor (BDNF) production in healthy Chinese adults. Clinical data also suggest that H-Val-Met-OH has beneficial effects on cognitive function in patients with mild cognitive impairment or Alzheimer's disease. Additionally, this compound has been shown to promote BDNF production in cultured mouse hippocampal neurons and enhance spatial memory retention in CD1 mice.

CAS 14486-09-0: val-met

H-Val-Met-OH

Ref: 3D-FV108230

H-Val-Met-OH

Ref: 01-4007536

L-Methionine, L-valyl-

Ref: IN-DA001K8V

H-Val-Met-OH

Ref: TR-V991705